Donor-specific, bone marrow derived mesenchymal stem cells (University Hospital Tuebingen)

N/A

Report date: 2024/11/08 20:00:30

Base Information

Drug NameDonor-specific, bone marrow derived mesenchymal stem cells (University Hospital Tuebingen)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCalcineurin inhibitors
TargetsCalcineurin
Therapy Area/IndicationsRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Tuebingen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Hospital Tuebingen
Active IndicationsN/A
Inactive IndicationsRejection of liver transplantation

Other Information

ATC CodeN/A
Related LinksN/A